borderline non-significantP = .06
At specific time points, the 5-year survival rate showed a borderline non-significant trend favoring first KT recipients (OR 1.63, 95% CI 0.97–2.73, P = .06), while the 10-year survival rate showed no difference (OR 0.94, 95% CI 0.67–1.32, P = .71).